European Infection Control Market worth $20.58 billion by 2030
The report "European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030", is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period.
Browse 468 market data Tables and 47 Figures spread through 476 Pages and in-depth TOC on "European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/european-infection-control-market-11051524.html
The market for infection control is growing due to several factors, including the increasing prevalence of healthcare-associated infections (HAIs), a rise in the number of surgeries, advancements in reprocessing technology, an increased focus on sterilization and disinfection in the food industry, improvements in sterilization equipment technology, and a growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals.
By sterilization products & services, the consumables & accessories segment is expected to grow at the highest CAGR during the forecast period.
The sterilization products & services segment is further classified into sterilization equipment, contract sterilization services, and consumables & accessories. The sterilization equipment segment accounted for the largest share of the European infection control market in 2024. The large share of this segment can be attributed to various factors, such as the growing number of surgical procedures, diagnostic interventions, strict standards set by regulatory agencies, advancements in sterilization technologies, and increasing healthcare-associated infections (HAIs).
By end user, the hospitals & clinics segment accounted for the largest share of the market in 2024.
By end user, the infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the infection control market in 2024. The overall demand for infection control in hospitals is primarily driven by the rise in hospital-acquired infections (HAIs), the expanding establishment of hospitals & clinics, and the increasing incidence of chronic & infectious diseases.
By country, Germany accounted for the largest share of the market in 2024.
The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. In 2024, Germany accounted for the largest share of the European infection control market due to several reinforcing factors, such as Germany's advanced healthcare infrastructure and the high volumes of surgeries & hospital admissions.
Key Players
Prominent players in the European infection control market include STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly-Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US) among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the European Infection Control Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
